The Global Oligonucleotide pool market was valued at $ 1,292.8 million in 2016 and expected to reach at $2,324 million by 2022 at a CAGR of 8.5% during the forecast period. The major factors responsible for the growth of global Oligonucleotide pool market are big pharmaceutical companies investing in oligonucleotide therapeutics for drug development, increased involvement of CMOs in manufacturing therapeutic oligonucleotides and wide application areas offered by the oligonucleotides, among others.
The growth barriers are complexity in the technology of manufacturing oligonucleotides and inaccuracy issues for the specific oligonucleotides among others.
The market is majorly categorized on the basis of types which is further segmented into DNA pool and RNA pool. On the basis of applications the market is segmented into research, diagnostics and therapeutics, and others. On the basis of end users the market is segmented into commercial research, pure academic research, and others and geographic regions. Globally, North America holds the largest market share of global Oligonucleotide pool market, registering 42.2 % in 2016.
The scope of Global Oligonucleotide pool market study includes the market value, market size and a detailed analysis of vendor products and strategies.
The leading players of the Global Oligonucleotide pool market are Agilent Technologies, Creative Biogene, CustomArray, Inc., Integrated DNA Technologies, Inc., MYcroarray, Sigma-Aldrich Co. LLC, TriLink BioTechnologies, LLC, Twist Bioscience and others.
Study Objectives of Oligonucleotide pool Market Development and Demand Forecast to 2022 Market
Ø To provide insights about factors, influencing and affecting the market growth
Ø To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
Ø To provide historically and forecast revenue of the market segments based on type, and sub-segment for Global Oligonucleotide pool market
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Ø To provide economic factors that influence the Global Oligonucleotide pool market
• Oligonucleotide pool companies
• Hospitals & Clinics
• Raw Material Suppliers
• Key executive (CEO and COO) and strategy growth manager
• On the basis of types, DNA oligonucleotides accounted for the largest market share of 66.9% in 2016.
• On the basis of applications. research accounted for the largest market share of 53.5% in 2016.
• US accounted for the largest market share of 77.6% in 2016, with a market value of USD 423.5 million and is projected to grow at a CAGR of 8.7% during the forecast period.
The reports also cover country level analysis:
• North America
• Western Europe
• Rest of Western Europe
• Eastern Europe
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa
1 Report Prologue
2 Market Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.2.1 Big pharmaceutical companies investing in oligonucleotide therapeutics for drug development
4.2.2 Increased involvement of CMOs in manufacturing therapeutic oligonucleotides.
4.2.3 Wide application areas offered by the oligonucleotides
4.3.1 Complexity in the manufacturing technique and inaccuracy of oligonucleotides.
5 Market Factor Analysis
5.1 Porters Five forces Model
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
6 Global Oligonucleotide Pool Market by Type
7 Global Oligonucleotide Pool Market by Application
8 Global Oligonucleotide Pool Market by End User
9 Global Oligonucleotide Pool Market by Region
9.2 North America
9.5 Middle East & Africa
10 Competitive Landscape
11 Company Profile
11.1 Agilent Technologies
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Creative Biogene
11.2.1 Company Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 CustomArray, Inc.
11.3.1 Company Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financial Overview
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.4 Integrated DNA Technologies, Inc.
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5.1 Company Overview
11.5.2 Product Overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Sigma-Aldrich Co. LLC
11.6.1 Company Overview
11.6.2 Product Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 TriLink BioTechnologies, LLC
11.7.1 Company Overview
11.7.2 Product Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Twist Bioscience
11.8.1 Company Overview
11.8.2 Product Overview
11.8.4 Key Developments
11.8.5 SWOT Analysis